冠状病毒是诱因，但免疫反应才是致命的。 - Suppr

Suppr

超能文献

Coronavirus is the trigger, but the immune response is deadly.

作者信息

Cron Randy Q

机构信息

Children's of Alabama, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35233-1711, USA.

出版信息

Lancet Rheumatol. 2020 Jul;2(7):e370-e371. doi: 10.1016/S2665-9913(20)30165-X. Epub 2020 May 29.

DOI:10.1016/S2665-9913(20)30165-X

PMID:32835232

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7259908/

Abstract

摘要

相似文献

Coronavirus is the trigger, but the immune response is deadly.冠状病毒是诱因，但免疫反应才是致命的。

Lancet Rheumatol. 2020 Jul;2(7):e370-e371. doi: 10.1016/S2665-9913(20)30165-X. Epub 2020 May 29.

The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.严重急性呼吸综合征冠状病毒木瓜样蛋白酶：结构、功能及设计的抗病毒化合物对其的抑制作用

Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29.

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?衰老、免疫与2019冠状病毒病：年龄如何影响宿主对冠状病毒感染的免疫反应？

Front Physiol. 2021 Jan 12;11:571416. doi: 10.3389/fphys.2020.571416. eCollection 2020.

Reviewing the Effects of Miltefosine and Suggesting It for the Treatment of Coronavirus Disease (COVID-19).回顾米替福新的作用并建议将其用于治疗冠状病毒病（COVID-19）。

Infect Dis (Auckl). 2020 Dec 1;13:1178633720977488. doi: 10.1177/1178633720977488. eCollection 2020.

Structural basis for human coronavirus attachment to sialic acid receptors.人类冠状病毒附着唾液酸受体的结构基础。

Nat Struct Mol Biol. 2019 Jun;26(6):481-489. doi: 10.1038/s41594-019-0233-y. Epub 2019 Jun 3.

Annu Rev Microbiol. 2021 Oct 8;75:19-47. doi: 10.1146/annurev-micro-110520-023212. Epub 2021 Jan 25.

COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics.新型冠状病毒肺炎与系统性红斑狼疮：聚焦免疫应答与治疗。

Front Immunol. 2020 Oct 30;11:589474. doi: 10.3389/fimmu.2020.589474. eCollection 2020.

Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.SARS-CoV-2 引起的全身性固有和适应性免疫反应与其他冠状病毒的关系。

Hum Vaccin Immunother. 2020 Dec 1;16(12):2980-2991. doi: 10.1080/21645515.2020.1802974. Epub 2020 Sep 2.

Genome-Wide Asymptomatic B-Cell, CD4 and CD8 T-Cell Epitopes, that are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Immune Targets for Pre-Emptive Pan-Coronavirus Vaccines.从新冠病毒中鉴定出全基因组无症状B细胞、CD4和CD8 T细胞表位，这些表位在人类和动物冠状病毒之间高度保守，可作为先发制全冠状病毒疫苗的免疫靶点。

bioRxiv. 2020 Sep 28:2020.09.27.316018. doi: 10.1101/2020.09.27.316018.

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.抗严重急性呼吸综合征冠状病毒刺突抗体通过 pH 非依赖和半胱氨酸蛋白酶非依赖 FcγR 途径触发人免疫细胞的感染。

J Virol. 2011 Oct;85(20):10582-97. doi: 10.1128/JVI.00671-11. Epub 2011 Jul 20.

引用本文的文献

Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome.重症 COVID-19 细胞因子风暴综合征中的噬血细胞性淋巴组织细胞增生症基因变异

Viruses. 2025 Aug 8;17(8):1093. doi: 10.3390/v17081093.

SARS-CoV-2 coinfection in patients with invasive pulmonary aspergillosis: clinical characteristics and prognosis.侵袭性肺曲霉病患者的新型冠状病毒2型合并感染：临床特征与预后

Ann Clin Microbiol Antimicrob. 2025 Jun 18;24(1):38. doi: 10.1186/s12941-025-00805-8.

IL-1 Family Blockade in Cytokine Storm Syndromes.白细胞介素-1 家族阻断在细胞因子风暴综合征中的应用。

Adv Exp Med Biol. 2024;1448:553-563. doi: 10.1007/978-3-031-59815-9_36.

COVID-19 Pneumonia and Cytokine Storm Syndrome.新型冠状病毒肺炎及细胞因子风暴综合征

Adv Exp Med Biol. 2024;1448:307-319. doi: 10.1007/978-3-031-59815-9_22.

SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）开放阅读框8作为细胞因子诱导的调节因子：证据及分子机制探索

Viruses. 2024 Jan 22;16(1):161. doi: 10.3390/v16010161.

The Multifaceted Immunology of Cytokine Storm Syndrome.细胞因子风暴综合征的多方面免疫学。

J Immunol. 2023 Apr 15;210(8):1015-1024. doi: 10.4049/jimmunol.2200808.

Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model.新型冠状病毒2感染的内皮细胞模型中的纤维蛋白凝块特征及抗凝反应

EJHaem. 2022 Mar 22;3(2):326-334. doi: 10.1002/jha2.407. eCollection 2022 May.

Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.新冠病毒感染发病率、严重程度和死亡率的风险和保护因素。

Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19.

COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use.新型冠状病毒肺炎与孕酮：第二部分。解析高严重性、免疫模式、免疫分级、孕酮及其潜在临床应用

Endocr Metab Sci. 2021 Dec 1;5:100110. doi: 10.1016/j.endmts.2021.100110. Epub 2021 Aug 8.

Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond.他汀类药物作为COVID-19的辅助治疗手段，以平息免疫性血栓形成及其他相关问题。

Front Pharmacol. 2021 Jan 19;11:579548. doi: 10.3389/fphar.2020.579548. eCollection 2020.

本文引用的文献

Anakinra for severe forms of COVID-19: a cohort study.阿那白滞素用于重症新型冠状病毒肺炎：一项队列研究。

Lancet Rheumatol. 2020 Jul;2(7):e393-e400. doi: 10.1016/S2665-9913(20)30164-8. Epub 2020 May 29.

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.在患有新冠肺炎、急性呼吸窘迫综合征和炎症反应过度的患者中使用高剂量阿那白滞素进行白细胞介素-1阻断：一项回顾性队列研究。

Lancet Rheumatol. 2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease.早期大剂量静脉注射阿那白滞素治疗重症 COVID-19 肺部疾病的安全性和有效性。

J Allergy Clin Immunol. 2020 Jul;146(1):213-215. doi: 10.1016/j.jaci.2020.05.002. Epub 2020 May 11.

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.在中重度新型冠状病毒肺炎中使用阿那白滞素靶向炎症级联反应：病例系列

Ann Rheum Dis. 2020 Oct;79(10):1381-1382. doi: 10.1136/annrheumdis-2020-217706. Epub 2020 May 6.

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.托珠单抗治疗伴有炎症过度反应和急性呼吸衰竭的重症 COVID-19 肺炎：意大利布雷西亚单中心 100 例患者研究。

Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3.

On the Alert for Cytokine Storm: Immunopathology in COVID-19.警惕细胞因子风暴：COVID-19 的免疫病理学。

Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. doi: 10.1002/art.41285. Epub 2020 May 10.

The Rheumatologist's Role in COVID-19.风湿病学家在COVID-19中的作用。

J Rheumatol. 2020 May 1;47(5):639-642. doi: 10.3899/jrheum.200334. Epub 2020 Mar 24.

Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.全外显子组测序揭示了与甲型流感（H1N1）致死病例中噬血细胞性淋巴组织细胞增生症和巨噬细胞活化综合征相关基因的突变。

J Infect Dis. 2016 Apr 1;213(7):1180-8. doi: 10.1093/infdis/jiv550. Epub 2015 Nov 23.

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.白细胞介素-1受体阻断与具有巨噬细胞活化综合征特征的脓毒症患者死亡率降低相关：对一项既往III期试验的重新分析

Crit Care Med. 2016 Feb;44(2):275-81. doi: 10.1097/CCM.0000000000001402.

Does Viral Hemorrhagic Fever Represent Reactive Hemophagocytic Syndrome?病毒性出血热是否代表反应性噬血细胞综合征？

J Rheumatol. 2015 Jul;42(7):1078-80. doi: 10.3899/jrheum.150108.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验